Supply of Doxycycline Hyclate Tablets

The contract pertains to the manufacture and supply of FDA-approved Doxycycline Hyclate Tablets, identified by NDC code 24658-0312-10, packaged in 10-tablet bottles for use by military medical services under a subcontract managed by the Defense Logistics Agency. The product is intended exclusively for Department of Defense requirements and must meet all applicable regulatory and quality standards for pharmaceuticals used in federal healthcare systems. Manufacturing must comply with current Good Manufacturing Practices and the tablets must retain FDA approval throughout the contract term. The contract is classified under NAICS code 325412, which designates pharmaceutical and medicine manufacturing, and the performance is governed by federal supply protocols without specific geographic limitations outlined. The award issuance date is July 15, 2026, and the subcontract is bound to the broader contractual framework managed under DLA's procurement system with official reference SPE2DX25D8022 and delivery identifier SPE2D926F7368.